Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 4 × Cancer Pain × Buprenorphine × Clear all

Phase

Status

Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Cancer Pain 2 Neoplasms 1 Chronic Pain 1

Interventions

Oxycodone 9 Fentanyl 4 Morphine 3 Ethanol 3 Naloxone 2 Buprenorphine 2 Acetaminophen 2 rofecoxib 1 Ultracet 1 Radiofrequency Ablation 1 Polyethylene Glycols 1 Methadone 1 Magnesium Hydroxide 1 Electrolytes 1 Duration of Therapy 1 Dosage Forms 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01809106 2015-12-24

CERP

Mario Negri Institute for Pharmacological Research

Phase 4 Completed

518 enrolled 11 charts

Cancer Pain, Neoplasms

NCT00916890 2014-01-09

Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain

Fondazione IRCCS Policlinico San Matteo di Pavia

Phase 4 Suspended

Cancer Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡